Target
Glucose-dependent insulinotropic receptor
Ligand
BDBM50523015
Substrate
n/a
Meas. Tech.
ChEMBL_1888841 (CHEMBL4390518)
EC50
261±n/a nM
Citation
 Harada, KMizukami, JWatanabe, TMori, GUbukata, MSuwa, KFukuda, SNegoro, TSato, MInaba, T Optimization of oxadiazole derivatives with a spirocyclic cyclohexane structure as novel GPR119 agonists. Bioorg Med Chem Lett 29:2100-2106 (2019) [PubMed]  Article 
Target
Name:
Glucose-dependent insulinotropic receptor
Synonyms:
G-protein coupled receptor 119 (GPR119) | GP119_HUMAN | GPR119 | Glucose-dependent insulinotropic receptor
Type:
Protein
Mol. Mass.:
36901.49
Organism:
Homo sapiens (Human)
Description:
Q8TDV5
Residue:
335
Sequence:
MESSFSFGVILAVLASLIIATNTLVAVAVLLLIHKNDGVSLCFTLNLAVADTLIGVAISGLLTDQLSSPSRPTQKTLCSLRMAFVTSSAAASVLTVMLITFDRYLAIKQPFRYLKIMSGFVAGACIAGLWLVSYLIGFLPLGIPMFQQTAYKGQCSFFAVFHPHFVLTLSCVGFFPAMLLFVFFYCDMLKIASMHSQQIRKMEHAGAMAGGYRSPRTPSDFKALRTVSVLIGSFALSWTPFLITGIVQVACQECHLYLVLERYLWLLGVGNSLLNPLIYAYWQKEVRLQLYHMALGVKKVLTSFLLFLSARNCGPERPRESSCHIVTISSSEFDG
  
Inhibitor
Name:
BDBM50523015
Synonyms:
CHEMBL4465577
Type:
Small organic molecule
Emp. Form.:
C21H27FN2O5S
Mol. Mass.:
438.513
SMILES:
CC1(C)C[C@@]2(CO1)CC[C@@H](CC2)OCc1nc(no1)-c1ccc(c(F)c1)S(C)(=O)=O |r,wU:4.4,9.13,(52.65,-3.28,;51.31,-4.06,;52.66,-4.82,;50.49,-5.36,;49,-4.96,;48.92,-3.43,;50.35,-2.87,;47.58,-4.33,;46.32,-5.23,;46.49,-6.77,;47.9,-7.39,;49.14,-6.5,;45.24,-7.67,;43.83,-7.04,;42.58,-7.94,;41.12,-7.47,;40.21,-8.72,;41.12,-9.97,;42.58,-9.49,;38.67,-8.72,;37.9,-7.39,;36.36,-7.39,;35.59,-8.72,;36.36,-10.05,;35.59,-11.39,;37.9,-10.05,;34.05,-8.72,;33.28,-7.4,;34.04,-10.26,;32.72,-9.48,)|
Structure:
Search PDB for entries with ligand similarity: